Protagonist Therapeutics (PTGX) Interest Coverage Ratio (2020)

Protagonist Therapeutics has reported Interest Coverage Ratio for 11 years, with the latest figure at 0.1 in Q4 2025.

• Quarterly Interest Coverage Ratio fell 100.07% year-over-year to 0.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.32 (down 100.07% YoY) and the FY2025 annual result came in at 0.32, down 119.08% from the prior year.
• Interest Coverage Ratio fell to 0.1 in Q4 2025 per PTGX's latest filing, from 150.75 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 296.42 in Q1 2024 and troughed at 55.3 in Q3 2023.
• A 5-year average of 16.04 and a median of 0.57 in 2023 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio plunged 13564.51% in 2022, then jumped 52190.3% in 2024.
• Over 5 years, Interest Coverage Ratio stood at 31.03 in 2021, then sank by 274.35% to 54.1 in 2022, then jumped by 74.13% to 13.99 in 2023, then soared by 1177.2% to 150.75 in 2024, then slumped by 100.07% to 0.1 in 2025.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.1, 150.75, and 21.6 for Q4 2025, Q4 2024, and Q3 2024 respectively.